Viewing Study NCT06316960


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-02-26 @ 8:46 PM
Study NCT ID: NCT06316960
Status: RECRUITING
Last Update Posted: 2024-08-22
First Post: 2024-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Sponsor: Children's Hospital of Soochow University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AML, Childhood View
None Relapse/Recurrence View
None Refractory AML View
None Core Binding Factor Acute Myeloid Leukemia View
None C-KIT Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Avapritinib View
None KIT View
None CBF AML View
None Childhood View
None Relapsed/Refractory View